Herbas VPB

Print
EN | LT
LT - USE OF 3-[5-AMINO-4-(3-CYANOBENZOYL)-PYRAZOL-1-YL]-N-CYCLOPROPYL-4-METHYLBENZAMIDE IN THE PREVENTION OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
EN - USE OF 3-[5-AMINO-4-(3-CYANOBENZOYL)-PYRAZOL-1-YL]-N-CYCLOPROPYL-4-METHYLBENZAMIDE IN THE PREVENTION OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/415
A61P 11/00
European patent
(11) Number of the document 3585383
(13) Kind of document T
(96) European patent application number 18819366.8
Date of filing the European patent application 2018-12-11
(97) Date of publication of the European application 2020-01-01
(45) Date of publication and mention of the grant of the patent 2021-03-24
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/GB2018/053591
Date 2018-12-11
PCT application publication
(87) Number WO 2019/116022
Date 2019-06-20
Priority applications
(30) Number Date Country code
201720622 2017-12-11 GB
201720624 2017-12-11 GB
201802354 2018-02-13 GB
201802353 2018-02-13 GB
Inventors
(72)
PARKIN, Jacqueline, GB
MACKINNON, Alastair, GB
Grantee
(73) Mereo BioPharma 1 Limited, 1 Cavendish Place, London, Greater London W1G 0QF, GB
Title
(54) USE OF 3-[5-AMINO-4-(3-CYANOBENZOYL)-PYRAZOL-1-YL]-N-CYCLOPROPYL-4-METHYLBENZAMIDE IN THE PREVENTION OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
  USE OF 3-[5-AMINO-4-(3-CYANOBENZOYL)-PYRAZOL-1-YL]-N-CYCLOPROPYL-4-METHYLBENZAMIDE IN THE PREVENTION OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE